Invention Grant
- Patent Title: Epirubicin derivatives
- Patent Title (中): 表柔比星衍生物
-
Application No.: US13508035Application Date: 2010-11-03
-
Publication No.: US08877720B2Publication Date: 2014-11-04
- Inventor: Hesheng Zhang
- Applicant: Hesheng Zhang
- Applicant Address: CN Tianjin CN Tianjin
- Assignee: Tianjin Hemay Bio-Tech Co., Ltd.,Tianjin Michele Sci-Tech Development Co., Ltd.
- Current Assignee: Tianjin Hemay Bio-Tech Co., Ltd.,Tianjin Michele Sci-Tech Development Co., Ltd.
- Current Assignee Address: CN Tianjin CN Tianjin
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: CN200910071116 20091103
- International Application: PCT/CN2010/078368 WO 20101103
- International Announcement: WO2011/054289 WO 20110512
- Main IPC: A61K31/70
- IPC: A61K31/70 ; C07H15/24 ; C07H19/044 ; A61K31/06 ; C07H19/04 ; C07H17/02 ; C07H15/252 ; C07H19/048
Abstract:
Disclosed are compounds represented by formula (I), pharmaceutically acceptable salts thereof, solvates thereof, and solvates of the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, W and are as defined in the present application.
Public/Granted literature
- US20130131001A1 Epirubicin Derivatives Public/Granted day:2013-05-23
Information query
